MAPT and Alzheimer disease: At present, diagnosing AD includes a test of cognitive impairment (The Mini Mental State Exam or Folstein test), in some cases supplemented by CSF assays for phosphorylated tau and Aβ, MRI for brain volume and PET scans for Aβ plaques (or glucose metabolism) in the brain [103].